TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34218469

Group type: EXPERIMENTAL
Intervention: Minimal split-thickness envelope flap (MSTEF)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Flap
Number of subjects: 28
Study: 36082909

Group type: EXPERIMENTAL
Intervention: Enterally delivered glutamine (0.5 g/kg/day)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1200
Study: 34116828

Group type: EXPERIMENTAL
Intervention: BDCA score (Brain Death After Cardiac Arrest Score)
Number of subjects: 569
Study: 32856530

Group type: EXPERIMENTAL
Intervention: Mechanically-expanded transcatheter heart valve
Number of subjects: 576

Group type: COMPARATOR
Intervention: Self-expanding transcatheter heart valve
Number of subjects: 576

Group type: COMPARATOR
Intervention: Normal/normal gait speed
Number of subjects: 576

Group type: COMPARATOR
Intervention: Slow/normal gait speed
Number of subjects: 576

Group type: COMPARATOR
Intervention: Normal/slow gait speed
Number of subjects: 576

Group type: COMPARATOR
Intervention: Slow/slow gait speed
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Slow gait speed at 1 year (regardless of baseline speed)
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Normalization of slow gait speed at 1 year
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: One-year gait speed
Number of subjects: 576
Study: 35691283

Group type: EXPERIMENTAL
Intervention: Ertugliflozin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ertugliflozin and Placebo
Number of subjects: 0
Study: 32048768

Group type: EXPERIMENTAL
Intervention: Any irAE
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Grade ≥3 irAE
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Each additional cycle of treatment
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Elevated lactate dehydrogenase
Number of subjects: 186
Study: 35956320

Group type: EXPERIMENTAL
Intervention: Heat-killed Lactococcus lactis subsp. cremoris H61
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34398800

Group type: EXPERIMENTAL
Intervention: TrackPAD mobile intervention (3 months)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Routine care only (control group)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: TrackPAD mobile intervention
Number of subjects: 39
Study: 35686212

Group type: EXPERIMENTAL
Intervention: Domiciliary nasal high flow (NHF) therapy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 200
Study: 32981552

Group type: EXPERIMENTAL
Intervention: Maternal age <35 years
Number of subjects: 1265

Group type: COMPARATOR
Intervention: Maternal age ≥35 years
Number of subjects: 1265

Group type: EXPERIMENTAL
Intervention: Serum oestradiol (E2) level >90th percentile
Number of subjects: 1265

Group type: COMPARATOR
Intervention: Serum oestradiol (E2) level ≤90th percentile
Number of subjects: 1265

Group type: EXPERIMENTAL
Intervention: Pregnancy outcome positive
Number of subjects: 1265

Group type: COMPARATOR
Intervention: Pregnancy outcome negative
Number of subjects: 1265
Study: 35358827

Group type: EXPERIMENTAL
Intervention: Inclined-adaptive footwear (IAF)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Footwear without adaptive technology (Control)
Number of subjects: 13
Study: 33761873

Group type: COMPARATOR
Intervention: Cadmium concentrations (0, 15, 30, 45, and 60 mg L-1) for 60 days
Number of subjects: 0
Study: 32221554

Group type: EXPERIMENTAL
Intervention: Cognitive Functional Therapy (CFT)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 39
Study: 34184965

Group type: EXPERIMENTAL
Intervention: Low-level laser combined with kinesiology taping (LLL-KT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High power laser combined with kinesiology taping (HPL-KT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham kinesiology taping (sham-KT)
Number of subjects: 30
Study: 34000676

Group type: EXPERIMENTAL
Intervention: DUI enforcement intensity
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: License suspension
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Jail penalties (1-3 days and 1-2 months)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Fine penalty and license points
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Nonlegal factors (informal sanction threat and vicarious experiences)
Number of subjects: 109
Study: 32445558

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 60
Study: 35305276

Group type: EXPERIMENTAL
Intervention: Individualized power training (IPT)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Generic power training (GPT)
Number of subjects: 49
Study: 32200999

Group type: EXPERIMENTAL
Intervention: Needing others to help read materials (English)
Number of subjects: 2770

Group type: EXPERIMENTAL
Intervention: Needing others to help read materials (Spanish)
Number of subjects: 2770

Group type: EXPERIMENTAL
Intervention: Problems learning because of difficulty reading (English)
Number of subjects: 2770

Group type: EXPERIMENTAL
Intervention: Problems learning because of difficulty reading (Spanish)
Number of subjects: 2770

Group type: EXPERIMENTAL
Intervention: Confidence with completing forms (English)
Number of subjects: 2770

Group type: EXPERIMENTAL
Intervention: Confidence with completing forms (Spanish)
Number of subjects: 2770

Group type: EXPERIMENTAL
Intervention: Combined health literacy screening items (English)
Number of subjects: 2770

Group type: EXPERIMENTAL
Intervention: Combined health literacy screening items (Spanish)
Number of subjects: 2770
Study: 33802709

Group type: EXPERIMENTAL
Intervention: Well Formulated Ketogenic Diet (WFKD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mediterranean Plus (Med-Plus)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-provided food phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delivered food phase
Number of subjects: 0
Study: 32434709

Group type: EXPERIMENTAL
Intervention: Conventional methods (n=101, 48%)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: e-Recruitment (n=60, 28%)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Health professional referrals (n=33, 16%)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Conventional methods
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: e-Recruitment
Number of subjects: 212
Study: 33966536

Group type: EXPERIMENTAL
Intervention: 16 stalking behavioral items from the National Stalking Helpline
Number of subjects: 924

Group type: EXPERIMENTAL
Intervention: Item response theory analyses
Number of subjects: 924
Study: 32658516

Group type: EXPERIMENTAL
Intervention: Expert discussing spanking research with anti-spanking lay comments
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Expert discussing spanking research with pro-spanking lay comments
Number of subjects: 180

Group type: COMPARATOR
Intervention: Car seat expert
Number of subjects: 180
Study: 36350591

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) for 8 weeks
Number of subjects: 208

Group type: COMPARATOR
Intervention: Escitalopram (10 to 20 mg, flexibly dosed) for 8 weeks
Number of subjects: 208

Group type: COMPARATOR
Intervention: Comparison of MBSR vs Escitalopram
Number of subjects: 208

Group type: COMPARATOR
Intervention: Escitalopram
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: MBSR
Number of subjects: 208
Study: 33622114

Group type: EXPERIMENTAL
Intervention: Alpelisib in combination with fulvestrant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fulvestrant alone
Number of subjects: 0
Study: 33034360

Group type: EXPERIMENTAL
Intervention: SmartSurfACE
Number of subjects: 2

Group type: COMPARATOR
Intervention: Streamlight
Number of subjects: 2
Study: 32993426

Group type: EXPERIMENTAL
Intervention: 90-minute mindfulness training plus 5-minute retreatment
Number of subjects: 209

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 209
Study: 32304828

Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic and resistance group exercise intervention, 52 weeks, 3 sessions/week, 1 hour/session (n=110)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Support group intervention (attention-control arm), 52 weeks, 1 hour/week (n=110)
Number of subjects: 220
Study: 36445709

Group type: EXPERIMENTAL
Intervention: Active recruitment method
Number of subjects: 104

Group type: COMPARATOR
Intervention: Traditional recruitment method
Number of subjects: 104
Study: 34779114

Group type: EXPERIMENTAL
Intervention: One-stage surgical protocol without ridge augmentation (Group A)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Two-stage surgical protocol with ridge augmentation (Group B)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 79
Study: 32690783

Group type: EXPERIMENTAL
Intervention: Unguided education and self-help website in addition to usual care
Number of subjects: 186

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 186
Study: 32960651

Group type: EXPERIMENTAL
Intervention: Working Mind program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qualitative data
Number of subjects: 0
Study: 32964474

Group type: EXPERIMENTAL
Intervention: 4D robustly optimized IMPT plans
Number of subjects: 10

Group type: COMPARATOR
Intervention: 3D robustly optimized IMPT plans
Number of subjects: 10
Study: 35843520

Group type: EXPERIMENTAL
Intervention: Tralokinumab (monotherapy or in combination with topical corticosteroids)
Number of subjects: 1976
Study: 34463409

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg, 25 mg)
Number of subjects: 7020

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7020
Study: 34983461

Group type: EXPERIMENTAL
Intervention: Group PM+ (gPM+) with enhanced care as usual (E-CAU)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Enhanced care as usual (E-CAU) only
Number of subjects: 46
Study: 32350730

Group type: EXPERIMENTAL
Intervention: Childcare centers
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: CACFP participants
Number of subjects: 297
Study: 34762527

Group type: EXPERIMENTAL
Intervention: Normoxia (NOR, 20.9% O2)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Hypoxia (HYP, 12.0% O2)
Number of subjects: 16
Study: 34267066

Group type: EXPERIMENTAL
Intervention: HPV testing
Number of subjects: 15518

Group type: COMPARATOR
Intervention: Age group comparison
Number of subjects: 15518

Group type: COMPARATOR
Intervention: Education level comparison
Number of subjects: 15518

Group type: COMPARATOR
Intervention: Ethnicity comparison
Number of subjects: 15518

Group type: EXPERIMENTAL
Intervention: Detection rates
Number of subjects: 15518
Study: 35435639

Group type: EXPERIMENTAL
Intervention: Tramadol (100-300 mg/day)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Open-label period
Number of subjects: 160
Study: 33822363

Group type: EXPERIMENTAL
Intervention: Emotional disclosure writing
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Peer helping writing
Number of subjects: 144

Group type: COMPARATOR
Intervention: Neutral control writing
Number of subjects: 144
Study: 33668012

Group type: EXPERIMENTAL
Intervention: CIP (critical inspiratory pressure) group (n = 12)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MIP60 (60% of maximal inspiratory pressure) group (n = 10)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham group (6 cmH2O; n = 8)
Number of subjects: 30
Study: 34153630

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Esketamine
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Ketamine and Esketamine (combined group)
Number of subjects: 54
Study: 35803302

Group type: EXPERIMENTAL
Intervention: Ventilatory strategy to prevent atelectasis (VESPA) with endotracheal intubation, recruitment maneuver, FiO2 titration (<100%), and PEEP of 8-10 cm H2O
Number of subjects: 76

Group type: COMPARATOR
Intervention: Standard ventilation (laryngeal mask airway, 100% FiO2, zero PEEP)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Ventilatory strategy to prevent atelectasis (VESPA)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Standard ventilation (control group)
Number of subjects: 76
Study: 34887855

Group type: EXPERIMENTAL
Intervention: Matrix M adjuvanted H5N1 vaccine (30μg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Matrix M adjuvanted H5N1 vaccine (7.5μg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Matrix M adjuvanted H5N1 vaccine (1.5μg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-adjuvanted H5N1 vaccine (30μg)
Number of subjects: 0
Study: 33554614

Group type: EXPERIMENTAL
Intervention: Catheter ablation with pulmonary vein isolation
Number of subjects: 778
Study: 33243213

Group type: EXPERIMENTAL
Intervention: Targeted education about simulation-based education and patient portrayal skills
Number of subjects: 40
Study: 36379652

Group type: EXPERIMENTAL
Intervention: Standard of care surgery (intraoperative neuronavigation and 5-ALA) + DTI and iUS
Number of subjects: 357

Group type: COMPARATOR
Intervention: Standard of care surgery (intraoperative neuronavigation and 5-ALA)
Number of subjects: 357
Study: 32057546

Group type: EXPERIMENTAL
Intervention: Interactive robot-enhanced hand rehabilitation (20 min additional to traditional rehabilitation, 3 times per week for 2 months)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Traditional hand rehabilitation program (60 min, 3 times per week for 2 months)
Number of subjects: 33
Study: 33930091

Group type: EXPERIMENTAL
Intervention: Pharmacist intervention tasks
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Medication reviews
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Communication with patients and healthcare professionals
Number of subjects: 2
Study: 34456582

Group type: EXPERIMENTAL
Intervention: Flurb group (received 100mg flurbiprofen during surgery)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (not receiving flurbiprofen)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study: 35742615

Group type: EXPERIMENTAL
Intervention: High-Intensity Circuit Training (HICT)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control
Number of subjects: 13
Study: 34544393

Group type: EXPERIMENTAL
Intervention: e-health treatment for urinary incontinence
Number of subjects: 496
Study: 32872078

Group type: EXPERIMENTAL
Intervention: Yiqi‐Huayu‐Tongsui (YQHYTS) granule
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 36075809

Group type: EXPERIMENTAL
Intervention: Knowledge of OA and total knee replacement (TKR)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Satisfaction with the decision-making process
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Importance attributed to avoiding surgery
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Importance attributed to time needed to relieve symptoms
Number of subjects: 193
Study: 32455853

Group type: EXPERIMENTAL
Intervention: Low-intensity physical exercise program (PEG, n = 16)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (CG, n = 16)
Number of subjects: 32
Study: 34458670

Group type: EXPERIMENTAL
Intervention: Total cystectomy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Partial cystectomy
Number of subjects: 56
Study: 32600140

Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT)
Number of subjects: 486

Group type: COMPARATOR
Intervention: Standard Dressing
Number of subjects: 486
Study: 34708422

Group type: EXPERIMENTAL
Intervention: DBBM
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: DBBM-C
Number of subjects: 66
Study: 32105984

Group type: EXPERIMENTAL
Intervention: Praliciguat (soluble guanylate cyclase stimulator)
Number of subjects: 184
Study: 35856838

Group type: EXPERIMENTAL
Intervention: 0.2% brimonidine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 33549254

Group type: EXPERIMENTAL
Intervention: Good glycemic control (mean glycated hemoglobin < 7%)
Number of subjects: 2285

Group type: EXPERIMENTAL
Intervention: Poor glycemic control (mean glycated hemoglobin ≥ 7%)
Number of subjects: 2285
Study: 35442343

Group type: EXPERIMENTAL
Intervention: Terlipressin (1 mg IV bolus q 4 hourly for 2 days) in TG2 group
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Terlipressin (1 mg IV bolus q 4 hourly for 5 days) in TG5 group
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control (0.9% normal saline, 10 mL IV bolus q 4 hourly) in TG0 group
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Terlipressin in TG2 group
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Terlipressin in TG5 group
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control in TG0 group
Number of subjects: 74
Study: 32803647

Group type: EXPERIMENTAL
Intervention: Elevated levels of orthorexic eating behavior (n = 35)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Low levels of orthorexic eating behavior (n = 35)
Number of subjects: 197
Study: 36599365

Group type: EXPERIMENTAL
Intervention: Individual Shear Rate Therapy (ISRT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Enhanced External Counterpulsation (EECP)
Number of subjects: 18
Study: 33612059

Group type: EXPERIMENTAL
Intervention: Lenalidomide maintenance (dose-escalated 2.5–10mg, 20/28 days per cycle for six months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lenalidomide maintenance
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lenalidomide maintenance and Observation
Number of subjects: 40
Study: 32430450

Group type: EXPERIMENTAL
Intervention: ETC120' (10 mg THC and 200 mg CBD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 36176534

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival (OS)
Number of subjects: 1179

Group type: EXPERIMENTAL
Intervention: Risk stratification based on nomogram score
Number of subjects: 1179

Group type: EXPERIMENTAL
Intervention: Cox regression analysis
Number of subjects: 1179

Group type: EXPERIMENTAL
Intervention: Calibration plot and C-index assessment
Number of subjects: 1179
Study: 34111674

Group type: EXPERIMENTAL
Intervention: Probiotic group (n = 21)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo group (n = 21)
Number of subjects: 42
Study: 32762012

Group type: EXPERIMENTAL
Intervention: IBBR with Acellular Dermal Matrix (ADM)
Number of subjects: 135

Group type: COMPARATOR
Intervention: IBBR without Acellular Dermal Matrix (ADM)
Number of subjects: 135
Study: 35893925

Group type: EXPERIMENTAL
Intervention: 5:2 Intermittent Fasting (IFT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Continuous Energy Restriction (CER)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both IFT and CER
Number of subjects: 34
Study: 33781101

Group type: EXPERIMENTAL
Intervention: Ankle-foot orthosis (AFO)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Laterally wedged insoles (LWI)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Comparison of AFO and LWI
Number of subjects: 39
Study: 35120753

Group type: EXPERIMENTAL
Intervention: Sustained-release pediatric melatonin (PRM)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 34934115

Group type: EXPERIMENTAL
Intervention: Aerobic exercise program
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Strength exercise program
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Mixed exercise program
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 86
Study: 35395220

Group type: EXPERIMENTAL
Intervention: Ileal glucose infusion (30g glucose and 3g 3-O-methylglucose)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 10
Study: 34297895

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention over 18 months
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Mass mailings of infographic materials
Number of subjects: 296
Study: 35599504

Group type: EXPERIMENTAL
Intervention: Conventional therapy plus proprioception training (PTR-PT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Modified Constraint-Induced Movement Therapy (PTR-mCIMT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional therapy (PTR)
Number of subjects: 40
Study: 32535703

Group type: EXPERIMENTAL
Intervention: Cone beam computed tomography (CBCT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Periapical radiograph
Number of subjects: 22

Group type: COMPARATOR
Intervention: Intrasurgical linear measurements
Number of subjects: 22
Study: 32233149

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab injections
Number of subjects: 41860

Group type: COMPARATOR
Intervention: Control periods (121-180, 181-240, 241-300, 301-361 days before index date)
Number of subjects: 41860
Study: 34521084

Group type: EXPERIMENTAL
Intervention: Platelet nadir <100 × 10^3/?L
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Platelet decrease >50% following CRRT initiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thrombocytopenia at CRRT initiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low platelet nadir and >50% platelet decrease
Number of subjects: 0
Study: 35705194

Group type: EXPERIMENTAL
Intervention: 9 g/day perilla oil (HOI)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 3 g/day perilla oil (LOI)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 36
Study: 35899772

Group type: EXPERIMENTAL
Intervention: Early antiplatelet treatment with 300 mg clopidogrel and 100 mg aspirin
Number of subjects: 1022

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1022
Study: 34444549

Group type: EXPERIMENTAL
Intervention: Two nudges
Number of subjects: 4000
Study: 32532777

Group type: EXPERIMENTAL
Intervention: Current AE analysis practices
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Awareness of specialist methods for AE analysis
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Undertaking specialist AE analyses
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Need for guidance on appropriate AE analysis
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Need for training on AE analysis
Number of subjects: 64
Study: 36115625

Group type: EXPERIMENTAL
Intervention: USCAP
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control
Number of subjects: 130